IONIS PARTNER NOVARTIS ANNOUNCES LP(A)HORIZON PHASE 3 TOPLINE RESULTS FOR PELACARSEN IN PATIENTS WITH ELEVATED LP(A) AND ESTABLISHED CARDIOVASCULAR DISEASE (CVD)

Reuters · 2d ago

Please log in to view news